moxifloxacine teva 400 mg, filmomhulde tabletten
teva nederland b.v. swensweg 5 2031 ga haarlem - moxifloxacinehydrochloride 436,3 mg/stuk samenstelling overeenkomend met ; moxifloxacine 400 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; ijzeroxide rood (e 172) ; macrogol 4000 ; magnesiumstearaat (e 470b) ; siliciumdioxide (e 551) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; ijzeroxide rood (e 172) ; macrogol 4000 ; magnesiumstearaat (e 470b) ; siliciumdioxide (e 551) ; titaandioxide (e 171), - moxifloxacin
digitalis purpurea boiron 4ch globuli
boiron - digitalis purpurea 4ch 1 % - globuli - 4ch - digitalis purpurea 4ch 1 %
digitalis purpurea boiron 5ch globuli
boiron - digitalis purpurea 5ch 1 % - globuli - 5ch - digitalis purpurea 5ch 1 %
digitalis purpurea boiron 7ch globuli
boiron - digitalis purpurea 7ch 1 % - globuli - 7ch - digitalis purpurea 7ch 1 %
digitalis purpurea boiron 9ch globuli
boiron - digitalis purpurea 9ch 1 % - globuli - 9ch - digitalis purpurea 9ch 1 %
digitalis purpurea boiron 30k globuli
boiron - digitalis purpurea 30k 1 % - globuli - 30k - digitalis purpurea 30k 1 %
digitalis purpurea boiron 200k globuli
boiron - digitalis purpurea 200k 1 % - globuli - 200k - digitalis purpurea 200k 1 %
digitalis purpurea boiron 200k globuli verp. éénmalig gebr.
boiron - digitalis purpurea 200k 1 % - globuli in verpakking voor éénmalig gebruik - 200k - digitalis purpurea 200k 1 %
clopidogrel acino
acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotische middelen - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.
moxifloxacine aurobindo 400 mg, filmomhulde tabletten
aurobindo pharma b.v. baarnsche dijk 1 3741 ln baarn - moxifloxacinehydrochloride samenstelling overeenkomend met ; moxifloxacine - filmomhulde tablet - cellulose, microkristallijn (e 460) ; hyprolose (e 463) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; natriumzetmeelglycolaat ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hyprolose (e 463) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; natriumzetmeelglycolaat (e468) ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - moxifloxacin